|
Gallego-Ortega A, Vidal-Villegas B, Norte-Munoz M, Salinas-Navarro M, Aviles-Trigueros M, Villegas-Perez MP, Vidal-Sanz M. 7,8-Dihydroxiflavone Maintains Retinal Functionality and Protects Various Types of RGCs in Adult Rats with Optic Nerve Transection. Int J Mol Sci. 2021 Oct 30;22(21):11815. doi: 10.3390/ijms222111815. PubMed PMID: 34769247; PubMed Central PMCID: PMC8584116.
AÑO: 2021; IF: 6.208
|
34769247
|
Vidal-Villegas B, Di Pierdomenico J, Gallego-Ortega A, Galindo-Romero C, Martinez-de-la-Casa JM, Garcia-Feijoo J, Villegas-Perez MP, Vidal-Sanz M. Systemic treatment with 7,8-Dihydroxiflavone activates TtkB and affords protection of two different retinal ganglion cell populations against axotomy in adult rats. Exp Eye Res. 2021 Sep;210:108694. doi: 10.1016/j.exer.2021.108694. Epub 2021 Jul 8. PubMed PMID: 34245756.
AÑO: 2021; IF: 3.77
|
|
Garcia-Ayuso D, Di Pierdomenico J, Garcia-Bernal D, Vidal-Sanz M, Villegas-Perez MP. Bone marrow-derived mononuclear stem cells in the treatment of retinal degenerations. Neural Regen Res. 2022 Sep;17(9):1937-1944. doi: 10.4103/1673-5374.335692. PubMed PMID: 35142670; PubMed Central PMCID: PMC8848608.
AÑO: 2022; IF: 6.1
|
|
Di Pierdomenico J, Gallego-Ortega A, Martinez-Vacas A, Garcia-Bernal D, Vidal-Sanz M, Villegas-Perez MP, Garcia-Ayuso D. Intravitreal and subretinal syngeneic bone marrow mononuclear stem cell transplantation improves photoreceptor survival but does not ameliorate retinal function in two rat models of retinal degeneration. Acta Ophthalmol. 2022 Sep;100(6):e1313-e1331. doi: 10.1111/aos.15165. Epub 2022 May 5. PubMed PMID: 35514078.
AÑO: 2022; IF: 3.4
|
|
Martinez-Vacas A, Di Pierdomenico J, Gallego-Ortega A, Valiente-Soriano FJ, Vidal-Sanz M, Picaud S, Villegas-Perez MP, Garcia-Ayuso D. Systemic taurine treatment affords functional and morphological neuroprotection of photoreceptors and restores retinal pigment epithelium function in RCS rats. Redox Biol. 2022 Nov;57:102506. doi: 10.1016/j.redox.2022.102506. Epub 2022 Oct 14. PubMed PMID: 36270186; PubMed Central PMCID: PMC9583577.
AÑO: 2022; IF: 11.4
|